Aller au contenu principal
Profil bibliographique

Dongyang Tang

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

41Publications signalées
892Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Ubiquitin and proteasome pathwaysCancer-related molecular mechanisms researchNanoparticle-Based Drug DeliveryNanoplatforms for cancer theranosticsMicroRNA in disease regulation

Les publications récentes

Accès ouvert 2026 article OpenAlex

GSDME mediated pyroptosis drives CCL5 secretion and dictates proteasome inhibitor efficacy in solid tumors

Dongyang Tang, Josh Haipeng Lei, Shiqi Lin, Jingbo Zhou et autres

Proteasome inhibitors show limited efficacy against solid tumors. We previously show the combination of Bortezomib with ammonium tetrathiomolybdate (TM) or AMD3100 could inhibit breast cancer growth rely on intact immune system. However, it remains to be explored the broad application of these …

mo, cn (code pays fourni par la source)

0 citations Pharmacological Research
Accès ouvert 2026 article OpenAlex

A miniaturized-tumor culture platform for developing anti-tumor immunotherapies

Yangyang Feng, Ling Li, Josh Haipeng Lei, Yuzhong Peng et autres

Rationale: is essential for investigating tumor-immune interactions and developing effective immunotherapies. However, current culture models often fail to maintain autologous immune cells or support high-throughput testing. To overcome these limitations, we establish and validate a novel miniaturized-tumor culture (MTC) platform. Methods: To …

mo, cn (code pays fourni par la source)

0 citations Theranostics
Accès ouvert 2026 article OpenAlex

Recent progress in cancer multidrug resistance and therapeutic options associated with protein damage response

Fangyuan Shao, Dongyang Tang, Lei Li, X X Xu et autres

Multidrug resistance (MDR) is a common and leading cause of treatment failure and mortality in cancer patient. While numerous biological processes contribute to drug resistance, recent studies have revealed that most anticancer drugs rapidly bind to and damage newly synthesized proteins upon …

mo, cn (code pays fourni par la source)

0 citations Protein & Cell
Accès ouvert 2025 article OpenAlex

RAD51B-EZH2 axis as a potential therapeutic target for TNBC through cell fate conversion

S. C. Lin, Dongyang Tang, Josh Haipeng Lei, Xiangpeng Chu et autres

Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer with higher histologic grade, poorer prognosis, and fewer treatment options due to the lack of reliable and effective molecular targets. Using a functional approach with the Sleeping Beauty (SB) transposon …

mo, hk, cn (code pays fourni par la source)

2 citations Cell Death and Disease
Accès ouvert 2025 article OpenAlex

Lars2-signaling mediates platinum resistance by accumulating cancer stem cell population and suppressing anti-tumor immunity

Yuqing Wang, Min Deng, Josh Haipeng Lei, Kai Miao et autres

Platinum-based chemotherapy remains a cornerstone of cancer treatment; however, its clinical efficacy is frequently compromised by acquired drug resistance. Our study elucidated a novel resistance mechanism mediated by LARS2 signaling in mammary tumors. Through comprehensive multi-omics analyses of cancer patients, mouse models, …

mo, cn (code pays fourni par la source)

2 citations Drug Resistance Updates
Accès ouvert 2025 article OpenAlex

Proteasome: Role in T Cell Function Regulation

Dongyang Tang, Xiaoran Wu, Josh Haipeng Lei, Yunfeng Qiao et autres

The proteasome plays a pivotal role in proteostasis and is deeply involved in various cellular processes. Currently, three proteasome inhibitors have been used for clinical therapies of liquid cancers with favorable efficacy, however they fail to achieve ideal efficiency in clinical trials …

mo (code pays fourni par la source)

3 citations International Journal of Biological Sciences
Accès ouvert 2025 article OpenAlex

CDK4/6 Inhibition Induces CD8 + T Cell Antitumor Immunity via MIF‐Induced Functional Orchestration of Tumor‐Associated Macrophages

Lin He, Yuzhong Peng, Jingbo Zhou, Dongyang Tang et autres

Abstract Cyclin‐dependent kinases 4 and 6 (CDK4/6) regulate cell cycle progression from the G 1 to S phase. Recently, CDK4/6 inhibition (CDK4/6i) is demonstrated to enhance antitumor immunity, as evidenced by increased tumor infiltration of CD8 + T cells; however, the mechanism …

mo, cn (code pays fourni par la source)

9 citations Advanced Science
Accès ouvert 2025 article OpenAlex

Suppressing protein damage response to overcome multidrug resistance in cancer therapy

Fangyuan Shao, Zongjie Li, Hao Xiao, Yujun Chen et autres

Multidrug resistance is a significant barrier in cancer therapy largely due to poorly understood regulatory mechanisms. Here we reveal that certain anticancer drugs can bind to newly synthesized proteins prior to reaching their canonical targets, resulting in various forms of protein damage. …

mo, cn (code pays fourni par la source)

5 citations Cell Discovery

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.